Journal of Cataract & Refractive Surgery
Volume 31, Issue 11 , Pages 2088-2092 , November 2005

Blue-light filtering intraocular lens in patients with diabetes: Contrast sensitivity and chromatic discrimination

,Accepted 5 April 2005.

References 

  1. Roy MS, Gunkel RD, Podgor MJ. Color vision defects in early diabetic retinopathy. Arch Ophthalmol. 1986;104:225–228
  2. Smith R. Diabetes and retinal function. [editorial] Br J Ophthalmol. 1990;74:385
  3. Fong DS, Barton FB, Bresnick GH. Impaired color vision associated with diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report No. 15; Early Treatment Diabetic Retinopathy Study Research Group. Am J Ophthalmol. 1999;128:612–617
  4. Lakowski R, Aspinall PA, Kinnear PR. Association between color vision losses and diabetes mellitus. Ophthalmic Res 1972/73; 4:145–159
  5. Ayed S, Jeddi A, Kallal Z. Diabète et trouble de la vision des couleurs détectés par le 100 hue de Farnsworth; dyschoroma-topsie diabétique. J Fr Ophtalmol. 1990;13:506–510
  6. Muntoni S, Serra A, Mascia C, Songini M. Dyschromatopsia in diabetes mellitus and its relation to metabolic control. Diabetes Care. 1982;5:375–378
  7. Trick GL, Burde RM, Gordon MO, et al. The relationship between hue discrimination and contrast sensitivity deficits in patients with diabetes mellitus. Ophthalmology. 1988;95:693–698
  8. Bresnick GH, Condit RS, Palta M, et al. Association of hue discrimination loss and diabetic retinopathy. Arch Ophthalmol. 1985;103:1317–1324
  9. Lombrail P, Cathelineau G, Gervais P, Thibult N. Abnormal color vision and reliable self-monitoring of blood glucose. Diabetes Care. 1984;7:318–321
  10. Roy MS, McCulloch C, Hanna AK, Mortimer C. Color vision in long-standing diabetes mellitus. Br J Ophthalmol. 1984;68:215–217
  11. Davies N, Morland A. Extent of foveal tritanopia in diabetes mellitus. Br J Ophthalmol. 2003;87:742–746
  12. Volbrecht VJ, Schneck ME, Adams AJ, et al. Diabetic short-wavelength sensitivity: variations with induced changes in blood glucose level. Invest Ophthalmol Vis Sci. 1994;35:1243–1246
  13. Cho N-C, Poulsen GL, Ver Hoeve JN, Nork TM. Selective loss of S-cones in diabetic retinopathy. Arch Ophthalmol. 2000;118:1393–1400
  14. Ernest PH. Light-transmission-spectrum comparison of foldable intraocular lenses. J Cataract Refract Surg. 2004;30:1755–1758
  15. Yap M. The effect of a yellow filter on contrast sensitivity. Ophthalmic Physiol Opt. 1984;4:227–232
  16. Kinney JAS, Schlichting CL, Neri DF, Kindness SW. Reaction time to spatial frequencies using yellow and luminance-matched neural goggles. Am J Optom Physiol Opt. 1983;60:132–138
  17. Kelly SA. Effect of yellow-tinted lenses on brightness. J Opt Soc Am A. 1990;7:1905–1911
  18. Kuyk TK, Thomas SR. Effect of short wavelength absorbing filters on Farnsworth-Munsell 100 hue test and hue identification task performance. Optom Vis Sci. 1990;67:522–531
  19. De Fez D, Luque J, Viqueira V. Enhancement of contrast sensitivity and losses of chromatic discrimination with tinted lenses. Optom Vis Sci. 2002;79:590–597
  20. Utku D, Atmaca LS. Farnsworth-Munsell 100-hue test for patients with diabetes mellitus. Ann Ophthalmol. 1992;24:205–208
  21. Della Sala S, Bertoni G, Somazzi L, et al. Impaired contrast sensitivity in diabetic patients with and without retinopathy: a new technique for rapid assessment. Br J Ophthalmol. 1985;69:136–142
  22. Sokol S, Moskowitz A, Skarf B, et al. Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol. 1985;103:51–54
  23. Montés-Micó R, Charman WN. Choice of spatial frequency for contrast sensitivity evaluation after corneal refractive surgery. J Refract Surg. 2001;17:646–651
  24. Montés-Micó R, Alió JL. Distance and near contrast sensitivity function after multifocal intraocular lens implantation. J Cataract Refract Surg. 2003;29:703–711
  25. Montés-Micó R, Alió JL, Muñoz G. Contrast sensitivity and spatial-frequency spectrum after laser refractive surgery. [letter] J Cataract Refract Surg. 2003;29:1650–1651
  26. Montés-Micó R, España E, Bueno I, et al. Visual performance of multifocal intraocular lenses; mesopic contrast sensitivity under distance and near conditions. Ophthalmology. 2004;111:85–96
  27. Kinnear PR, Sahraie A. New Farnsworth-Munsell 100 hue test norms of normal observers for each year of age 5–22 and for age decades 30–70. Br J Ophthalmol. 2002;86:1408–1411
  28. François J, Verriest G. On acquired deficiency of color vision, with special reference to its detection and classification by means of the tests of Farnsworth. Vision Res. 1961;1:201–219
  29. Bowman KJ. Cole BL A recommendation for illumination of the Farnsworth-Munsell 100-hue test. Am J Optom Physiol Opt. 1980;57:839–843
  30. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. 52nd WMA general assembly, Edinburgh, Scotland, October 2000
  31. Brown PK, Wald G. Visual pigments in human and monkey retinas. Nature. 1963;200:37–43
  32. Willians DR, MacLeod DIA, Hayhoe MM. Foveal tritanopia. Visioin Res. 1981;21:1341–1356
  33. Brindley GS. The summation areas of human color receptive mechanisms at increment threshold. J Physiol. 1954;124:400–408
  34. Gastaud P, Vola J, Saracco JB, et al. Diabetic dyschromatopsia: pathogenic hypothesis. Doc Ophthalmol Proc Ser. 1987;46:387–390
  35. Hood DC, Benimoff NI, Greenstein VC. The response range of the blue-cone pathways: a source of vulnerability to disease. Invest Ophthalmol Vis Sci. 1984;25:864–867
  36. Gündüz K, Arden GB, Perry S, et al. Color vision defects in ocular hypertension and glaucoma; quantification with a computer-driven color television system. Arch Ophthalmol. 1988;106:929–935
  37. Mollon JD. What is odd about the short-wavelength mechanism and why is it disproportionately vulnerable to acquired damage? Report of a discussion. Doc Ophthalmol Proc Ser. 1982;33:145–149
  38. Farnsworth D. Tritanomalous vision as a threshold function. Farbe. 1955;4:185–196discussion, 196–197
  39. Greenstein VC, Hood DC, Campbell CJ. The use of a flash-on-flash paradigm to assess sensitivity changes due to retinal disease. Invest Ophthalmol Vis Sci. 1982;23:102–112
  40. Nork TM, Millecchia LL, Strickland BD, et al. Selective loss of blue cones and rods in human retinal detachment. Arch Ophthalmol. 1995;113:1066–1073
  41. Kessel L, Alsing A, Larsen M. Diabetic versus non-diabetic color vision after cataract surgery. Br J Ophthalmol. 1999;83:1042–1045
  42. Hardy KJ, Lipton J, Scase MO, et al. Detection of color vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas. Br J Ophthalmol. 1992;76:461–464
  43. Green FD, Ghafour IM, Allan D, et al. Color vision of diabetics. Br J Ophthalmol. 1985;69:533–536
  44. Aspinall PA, Kinnear PR, Duncan LJP, Clarke BF. Prediction of diabetic retinopathy from clinical variables and color vision data. Diabetes Care. 1983;6:144–148
  45. Moloney J, Drury MI. Retinopathy and retinal function in insulin-dependent diabetes mellitus. Br J Ophthalmol. 1982;66:759–761
  46. Ghafour IM, Foulds WS, Allan D, McClure E. Contrast sensitivity in diabetic subjects with and without retinopathy. Br J Ophthalmol. 1982;66:492–495

 No author has a financial and proprietary interest in any material or method mentioned.

PII: S0886-3350(05)00676-0

doi: 10.1016/j.jcrs.2005.04.029

Journal of Cataract & Refractive Surgery
Volume 31, Issue 11 , Pages 2088-2092 , November 2005

Article Tools

* Image Usage & Resolution